Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study

The efficacy of tocilizumab on the prognosis of severe/critical COVID-19 patients is still controversial so far. We aimed to delineate the inflammation characteristics of severe/critical COVID-19 patients and determine the impact of tocilizumab on hospital mortality. Here, we performed a retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qin, Xu, Yu, Xiang, Ying, Wang, Bin, Yuan, Zhiquan, Shan, Yifan, Zhang, Wenjing, Wu, Na, Xia, Tingting, Li, Chengying, Xie, Weijia, Jia, Xiaoyue, Yu, Zubin, Bai, Li, Li, Yafei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193270/
https://www.ncbi.nlm.nih.gov/pubmed/34131411
http://dx.doi.org/10.7150/ijbs.56952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193270/
https://www.ncbi.nlm.nih.gov/pubmed/34131411
http://dx.doi.org/10.7150/ijbs.56952

Ejemplares similares